Evidence map›Paper›PMID 36009387›Full record

ArticleBiomedicines2022

T-Cell Infiltration and Immune Checkpoint Expression Increase in Oral Cavity Premalignant and Malignant Disorders.

Subin Surendran, Usama Aboelkheir, Andrew A Tu, William J Magner, S Lynn Sigurdson, Mihai Merzianu, Wesley L Hicks, Amritha Suresh, Keith L Kirkwood, Moni A Kuriakose

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Subin SurendranHead & Neck Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Usama AboelkheirHead & Neck Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Andrew A TuHead & Neck Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.ORCID 0000-0002-7982-172X
William J MagnerHead & Neck Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.ORCID 0000-0001-5314-9536
S Lynn SigurdsonHead & Neck Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Mihai MerzianuPathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Wesley L HicksHead & Neck Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Amritha SureshHead & Neck Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Keith L KirkwoodPeriodontics and Endodontics, University at Buffalo School of Dental Medicine, Buffalo, NY 14214, USA.ORCID 0000-0003-4519-8973
Moni A KuriakoseHead & Neck Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Roswell Park Comprehensive Cancer Center · USUniversity at Buffalo, State University of New York · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Investigating the Role of Polymerase kappa in Melanoma Heterogeneity and Drug ResistanceF31CA200341 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI TEMPRINE, KELSEY · 2015 to 2017
$83k
NCI NIH HHS F31 CA200341NCI NIH HHS P30 CA016056
6 · The paper itself

Abstract

The immune cell niche associated with oral dysplastic lesion progression to carcinoma is poorly understood. We identified T regulatory cells (Treg), CD8+ effector T cells (Teff) and immune checkpoint molecules across oral dysplastic stages of oral potentially malignant disorders (OPMD). OPMD and oral squamous cell carcinoma (OSCC) tissue sections (N = 270) were analyzed by immunohistochemistry for Treg (CD4, CD25 and FoxP3), Teff (CD8) and immune checkpoint molecules (PD-1 and PD-L1). The Treg marker staining intensity correlated significantly (p < 0.01) with presence of higher dysplasia grade and invasive cancer. These data suggest that Treg infiltration is relatively early in dysplasia and may be associated with disease progression. The presence of CD8+ effector T cells and the immune checkpoint markers PD-1 and PD-L1 were also associated with oral cancer progression (p < 0.01). These observations indicate the induction of an adaptive immune response with similar Treg and Teff recruitment timing and, potentially, the early induction of exhaustion. FoxP3 and PD-L1 levels were closely correlated with CD8 levels (p < 0.01). These data indicate the presence of reinforcing mechanisms contributing to the immune suppressive niche in high-risk OPMD and in OSCC. The presence of an adaptive immune response and T-cell exhaustion suggest that an effective immune response may be reactivated with targeted interventions coupled with immune checkpoint inhibition.

Indexed as

immune cell infiltrationimmune checkpointimmunotherapyoncogenesisoral canceroral potentially malignant disorderstumorigenesistumor microenvironment

Identifiers

PMID36009387
PMCPMC9404942
OpenAlexW4289109827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.